Literature DB >> 6127616

The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists.

D R Haubrich, A B Pflueger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127616

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  15 in total

Review 1.  Retinal dopamine D1 and D2 receptors: characterization by binding or pharmacological studies and physiological functions.

Authors:  M Schorderet; J Z Nowak
Journal:  Cell Mol Neurobiol       Date:  1990-09       Impact factor: 5.046

2.  Dopamine D2 receptors in brain and anterior pituitary recognize agonist and antagonist actions of (-)-3-PPP.

Authors:  S R George; M Watanabe; P Seeman
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?

Authors:  C J Fowler; G Thorell; M Andersson; O Magnusson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-10       Impact factor: 3.000

4.  Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter.

Authors:  Rong Chen; Conor P Daining; Haiguo Sun; Rheaclare Fraser; Stephanie L Stokes; Michael Leitges; Margaret E Gnegy
Journal:  J Neurochem       Date:  2013-03-18       Impact factor: 5.372

5.  Altered dopamine release and uptake kinetics in mice lacking D2 receptors.

Authors:  Yvonne Schmitz; Claudia Schmauss; David Sulzer
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

6.  Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.

Authors:  B L Largent; A L Gundlach; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine.

Authors:  G Laschinski; B Kittner; M Bräutigam
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

8.  Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP.

Authors:  S Hjorth; A Carlsson; D Clark; K Svensson; H Wikström; D Sanchez; P Lindberg; U Hacksell; L E Arvidsson; A Johansson
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Effect of low-dose bromocriptine in treatment of psychosis: the dopamine autoreceptor-stimulation strategy.

Authors:  H Y Meltzer; T Kolakowska; A Robertson; B J Tricou
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis.

Authors:  F Brown; W Campbell; P J Mitchell; K Randall
Journal:  Br J Pharmacol       Date:  1985-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.